High-flow nasal oxygen is the reference treatment in acute hypoxemic respiratory failure: Con

Over the past decade and boosted by the coronavirus disease 2019 (COVID-19) pandemic, high-flow nasal oxygen (HFNO) has been increasingly used in the intensive care unit (ICU) to treat acute hypoxemic respiratory failure (AHRF). In this review, we show that despite this wide and rapid increase in th...

Description complète

Détails bibliographiques

Auteurs principaux:	Gabriel Kemoun, Alexandre Demoule
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2025-07-01
Collection:	Journal of Intensive Medicine
Sujets:	Acute respiratory failure Intubation Low-income country High flow nasal cannula Patient self-inflicted lung injury Carbon emissions
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2667100X24001415
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!